Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
LGHTvsIBRNETF Comparison
Langar Global HealthTech ETF (LGHT) and iShares Neuroscience and Healthcare ETF (IBRN) belong to the same industry segment: Healthcare Technology. Both ETFs have the same top 3 sector exposures: and Health Care. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.47% for IBRN. LGHT is down -8.11% year-to-date (YTD) with - in YTD flows. IBRN performs better with -2.32% YTD performance, and - in YTD flows. Run a side-by-side ETF comparison of LGHT and IBRN below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LGHT vs IBRN performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LGHT IBRN | -3.87%-0.41% | -8.66%-1.92% | -8.11%-2.32% | -8.02%+34.51% | n/a+35.71% | n/an/a |
| Flows | LGHT IBRN | -- | -$101K- | -- | +$1M- | --$1M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LGHT IBRN | +18.35%+25.30% | +21.19%+28.21% | n/a+24.21% | n/an/a |
| Max drawdown | LGHT IBRN | -12.49%-8.08% | -13.88%-23.45% | n/a-34.98% | n/an/a |
| Max drawdown duration | LGHT IBRN | 63d49d | 135d148d | n/a338d | n/an/a |
LGHT | IBRN | |
Last sale 3/12/2026 at 1:30 PM | $8.96 | $31.00 |
| Previous close 03/12/2026 | $9.19 | $31.55 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LGHT | IBRN | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LGHT | IBRN | |
|---|---|---|
| Last price | $8.96 | $31.00 |
| 1D performance | -2.49% | -1.73% |
| AuM | $3.67 M | $4.73 M |
| E/R | 0.85% | 0.47% |
LGHT | IBRN | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Langar Investment Management | iShares |
| Benchmark | - | NYSE FactSet Global Neuro Biopharma and MedTech Index |
| N° of holdings | 25 | 46 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 10, 2024 | August 24, 2022 |
| ESG | Yes | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the LGHT and IBRN ETFs performed in 2026?
As of March 11, 2026, LGHT is down -8.11% year-to-date (YTD), while IBRN has lost -2.32%. That puts IBRN better performer ahead so far this year.
Which ETF is attracting more investor money: LGHT or IBRN?
Year-to-date, the LGHT ETF saw - in flows, compared to - for IBRN.
Which ETF is more volatile: LGHT or IBRN?
Over the past year, LGHT had a volatility of 21.19%, while IBRN experienced 28.21%.
Which ETF is bigger: LGHT or IBRN?
As of March 11, 2026, LGHT holds $3.67 M in assets under management (AUM), while IBRN manages $4.73 M.
What sectors do the LGHT and IBRN ETFs invest in?
LGHT leans toward sectors like Health Care. Meanwhile, IBRN focuses on Health Care.
What are the top holdings of the LGHT ETF and IBRN ETF?
LGHT top holdings include INTUITIVE SURGICAL, RESMED and US36266G1076. IBRN holds in its top three: US74006W2070, AXSOME THERA CMN STK and ALKERMES.
Which ETF is more diversified: LGHT or IBRN?
LGHT holds 25 securities with 75.77% of its assets in the top 15. IBRN has 59 securities and a top 15 weight of 57.3%.
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
